BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 17984305)

  • 21. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
    Pender MP; Csurhes PA; Smith C; Beagley L; Hooper KD; Raj M; Coulthard A; Burrows SR; Khanna R
    Mult Scler; 2014 Oct; 20(11):1541-4. PubMed ID: 24493474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
    Tzartos JS; Khan G; Vossenkamper A; Cruz-Sadaba M; Lonardi S; Sefia E; Meager A; Elia A; Middeldorp JM; Clemens M; Farrell PJ; Giovannoni G; Meier UC
    Neurology; 2012 Jan; 78(1):15-23. PubMed ID: 22156987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis.
    Laurence M; Benito-León J
    Mult Scler Relat Disord; 2017 Aug; 16():8-14. PubMed ID: 28755684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed death 1 is highly expressed on CD8
    Cencioni MT; Magliozzi R; Nicholas R; Ali R; Malik O; Reynolds R; Borsellino G; Battistini L; Muraro PA
    Immunology; 2017 Dec; 152(4):660-676. PubMed ID: 28767147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P; Hansen HJ; Haahr S
    Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of Epstein-Barr virus infection with CXCR3
    van Langelaar J; Wierenga-Wolf AF; Samijn JPA; Luijks CJM; Siepman TA; van Doorn PA; Bell A; van Zelm MC; Smolders J; van Luijn MM
    Eur J Immunol; 2021 Mar; 51(3):626-633. PubMed ID: 33152118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr Virus and Multiple Sclerosis.
    Houen G; Trier NH; Frederiksen JL
    Front Immunol; 2020; 11():587078. PubMed ID: 33391262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 30. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP; Mautner J; Mitterreiter JG; Hintzen RQ; Verjans GM
    Mult Scler; 2016 Mar; 22(3):279-91. PubMed ID: 26041797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.
    Aloisi F; Cross AH
    J Neuroimmunol; 2022 Oct; 371():577935. PubMed ID: 35931008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
    Owens GP; Bennett JL
    Mult Scler; 2012 Sep; 18(9):1204-8. PubMed ID: 22685062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis.
    Zivadinov R; Zorzon M; Weinstock-Guttman B; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):620-5. PubMed ID: 19168469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversial role of Epstein-Barr virus in multiple sclerosis.
    Fatima N; Toscano MP; Hunter SB; Cohen C
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):246-52. PubMed ID: 21494180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP
    Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis?
    Hassani A; Khan G
    Front Immunol; 2019; 10():695. PubMed ID: 31001286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
    Wunsch M; Hohmann C; Milles B; Rostermund C; Lehmann PV; Schroeter M; Bayas A; Ulzheimer J; Mäurer M; Ergün S; Kuerten S
    Viruses; 2016 Apr; 8(4):105. PubMed ID: 27120609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus cause of multiple sclerosis.
    Tselis A
    Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
    Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.